ArticleAlzheimer's research & therapy2014

First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model.

Eva Kontsekova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.